The A53T Mutation in α-Synuclein Enhances Proinflammatory Activation in Human Microglia Upon Inflammatory Stimulus

Biol Psychiatry. 2025 Apr 1;97(7):730-742. doi: 10.1016/j.biopsych.2024.07.011. Epub 2024 Jul 17.

Abstract

Background: Parkinson's disease (PD) is the second most common neurodegenerative disease, following Alzheimer's. It is characterized by the aggregation of α-synuclein into Lewy bodies and Lewy neurites in the brain. Microglia-driven neuroinflammation may contribute to neuronal death in PD; however, the exact role of microglia remains unclear and has been understudied. The A53T mutation in the gene coding for α-synuclein has been linked to early-onset PD, and exposure to A53T mutant human α-synuclein increases the potential for inflammation of murine microglia. To date, its effect has not been studied in human microglia.

Methods: Here, we used 2-dimensional cultures of human pluripotent stem cell-derived microglia and transplantation of these cells into the mouse brain to assess the cell autonomous effects of the A53T mutation on human microglia.

Results: We found that A53T mutant human microglia had an intrinsically increased propensity toward proinflammatory activation upon inflammatory stimulus. Additionally, transplanted A53T mutant microglia showed a strong decrease in catalase expression in noninflammatory conditions and increased oxidative stress.

Conclusions: Our results indicate that A53T mutant human microglia display cell autonomous phenotypes that may worsen neuronal damage in early-onset PD.

Keywords: Disease modeling; Human pluripotent stem cells; Inflammation; Microglia; Parkinson’s disease; Xenotransplantation.

MeSH terms

  • Animals
  • Brain / metabolism
  • Catalase / genetics
  • Catalase / metabolism
  • Cells, Cultured
  • Humans
  • Inflammation / genetics
  • Inflammation / metabolism
  • Mice
  • Microglia* / metabolism
  • Mutation*
  • Neuroinflammatory Diseases / genetics
  • Neuroinflammatory Diseases / metabolism
  • Oxidative Stress
  • Parkinson Disease / genetics
  • Parkinson Disease / metabolism
  • alpha-Synuclein* / genetics
  • alpha-Synuclein* / metabolism

Substances

  • alpha-Synuclein
  • SNCA protein, human
  • Catalase